| Date Filed | Type | Description |
| 08/14/2023 |
4
| Collier Kathryn J (Director) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 15,000 options to buy
@ $1.36, valued at
$20.4k
|
|
| 08/14/2023 |
4
| Witz Pascale (Director) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 15,000 options to buy
@ $1.36, valued at
$20.4k
|
|
| 08/14/2023 |
4
| Rosen Hugh (Director) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 15,000 options to buy
@ $1.36, valued at
$20.4k
|
|
| 08/14/2023 |
4
| RASTETTER WILLIAM H (Director) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 15,000 options to buy
@ $1.36, valued at
$20.4k
|
|
| 08/14/2023 |
4
| PAPADOPOULOS STELIOS (Director) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 15,000 options to buy
@ $1.36, valued at
$20.4k
|
|
| 08/14/2023 |
4
| Nunn Jason Raleigh (Director) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 15,000 options to buy
@ $1.36, valued at
$20.4k
|
|
| 08/14/2023 |
4
| Klassen Preston (President & Head of R & D) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 225,000 options to buy
@ $1.36, valued at
$306k
|
|
| 08/14/2023 |
4
| Huang Alice Shih-hou (Director) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 15,000 options to buy
@ $1.36, valued at
$20.4k
|
|
| 08/14/2023 |
4
| CALSADA CRISPINA (CFO) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 375,000 options to buy
@ $1.36, valued at
$510k
|
|
| 08/14/2023 |
4
| Hagan Joseph P (President and CEO) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 1,312,500 options to buy
@ $1.36, valued at
$1.8M
|
|
| 08/14/2023 |
4
| BALTIMORE DAVID (Director) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 15,000 options to buy
@ $1.36, valued at
$20.4k
|
|
| 08/14/2023 |
4
| Aker Christopher Ray (Sr. VP & General Counsel) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 393,750 options to buy
@ $1.36, valued at
$535.5k
|
|
| 06/12/2023 |
4
| Klassen Preston (President & Head of R & D) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 350,000 options to buy
@ $1.46, valued at
$511k
|
|
| 06/12/2023 |
3
| Klassen Preston (President & Head of R & D) has filed a Form 3 on Regulus Therapeutics Inc. |
| 04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/17/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Collier Kathryn J (Director) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 90,000 options to buy
@ $0.27, valued at
$24.3k
|
|
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Rosen Hugh (Director) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 90,000 options to buy
@ $0.27, valued at
$24.3k
|
|
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Witz Pascale (Director) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 90,000 options to buy
@ $0.27, valued at
$24.3k
|
|
| 05/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/11/2022 |
4
| CALSADA CRISPINA (CFO) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 50,000 options to buy
@ $1.31, valued at
$65.5k
|
|
| 05/11/2022 |
4
| Aker Christopher Ray (Sr. VP & General Counsel) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 70,000 options to buy
@ $1.31, valued at
$91.7k
|
|
| 03/01/2022 |
4
| Drygin Denis (Chief Scientific Officer) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Bought 76,686 shares
@ $0.23, valued at
$17.6k
|
|
| 02/07/2022 |
4
| Drygin Denis (Chief Scientific Officer) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Bought 23,314 shares
@ $0.23, valued at
$5.4k
|
|
| 01/26/2022 |
4
| Drygin Denis (Chief Scientific Officer) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 400,000 options to buy
@ $0.26, valued at
$104k
|
|
|